Displaying 11 (all) recruiting clinical trials.
-
Prospective Databased of Clinical Outcomes Following Cryotherapy for ablation of clinically localized prostate cancer
The purpose of this study is to better understand how well Cryo Ablation treats prostate cancer and the long-term effects of this treatment of sexual ... -
NYU Winthrop Hospital Minimally Invasive Treatment for BPH Database
The rationale and specific goal of this research is to build a database of patients undergoing the Urolift or Rezum procedure for benign prostatic hyperplasia ... -
NYU Cooperative Prostate Cancer Tissue Resource
The purpose of this study is to collect prostate tissue, blood, urine, and health information from a large group of patients for whom prostate cancer ... -
A Phase 1b/2 Open-Label Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer
The purpose of the study is to determine the safety and efficacy of the treatments: AB928, a novel adenosine receptor blocker, plus zimberelimab, an anti-PD1 ... -
Comparing UroLift Experience Against Rezum (C.L.E.A.R. Study)
The purpose of this study is to compare two different minimally invasive procedures often used to treat the symptoms of benign prostatic hyperplasia (BPH): the ... -
INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer
The purpose of the trial is to determine whether Darolutamide plus radiation therapy (RT) is non-inferior to gonadotropin releasing hormone (GnRH) agonist and bicalutamide plus ... -
A PHASE 1/2 STUDY OF REGN5678 (ANTI-PSMAXCD28) WITH CEMIPLIMAB (ANTI-PD-1) IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER [Regeneron 5678-ONC-1879]
The purpose of the trial is to determine safety and tolerability of REGN5678 alone and in combination with cemiplimab in treatment-experienced metastatic castration-resistant prostate cancer ... -
10301 - A Phase I and Randomized Phase II Trial of Radium-223 dichloride M3814 & Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
The purpose of the study is to determine the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab ... -
Anabolic Androgenic Steroid Use among Gay Bisexual and Queer Men in NYC
The purpose of this research study is to understand the experiences of gay, bisexual, and queer (GBQ) men who use anabolic androgenic steroids (AAS), also ... -
A Phase 1 and 2a trial of LAVA-1207 in patients with therapy refractory metastatic castration resistant prostate cancer
The purpose of the study is to determine and investigate the safety, tolerability, pharmacokinetics, pharmacodynamics, immunogenicity and preliminary antitumor activity of LAVA-1207, a bi-specific antibody ...